Market Insight Peptides

Panel Discussion: AI In The Development Of Peptide Therapeutics

Kai Hilpert

Professor

St George’s University of London

Sergio Martinez Cuesta

Principal Data Scientist

AstraZeneca

David Rodriguez Diaz

Associate Director

Novo Nordisk

15 July, 2026

Watch time: 26 Minutes

Highlights

Takeaways

•Using AI to design and optimise peptide sequences
•Enhancing stability and delivery through predictive modeling
•Overcoming data limitations in peptide ML applications

Moderator: Sergio Martinez Cuesta, Principal Data Scientist, AstraZeneca

Panellists:
Kai Hilpert, Professor, St George’s University of London
David Rodriguez Diaz, Associate Director, Novo Nordisk

PREMIUM CONTENT

Want that extra level of detail?
Subscribe and get access to full length presentations and write-ups giving you the insights to stay ahead of the curve.

Please note once we have received payment it can take 24 hours for your account to be updated to the premium access.

Upgrade

Full Video Transcript